IDEXX Laboratories announces 2014 third quarter results
IDEXX reported that revenues for the third quarter of 2014 increased 13% versus the prior year period to $384 million. Strong business momentum supports increase in 2014 Adjusted EPS guidance to $3.85 to $3.90 and preliminary 2015 outlook for 13% to 14% normalized organic revenue growth. October 24, 2014